<?xml version="1.0" encoding="UTF-8"?>
<fig id="pone.0204870.g003" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0204870.g003</object-id>
 <label>Fig 3</label>
 <caption>
  <p>Representative PD-1 and PD-L1/PAX5 immunohistochemical stainings at 400x magnification with 
   <italic>untreated</italic> (A-D) and 
   <italic>treated</italic> (E-H) patients. Brown membranous staining indicates PD-1+ or PD-L1+ cells, while red nuclear staining indicates PAX5+ cells. 
   <italic>Untreated</italic>: (A) Case 9 biopsy 1 (average 4% PD-1+ leukocytes), (B) case 9 biopsy 2 (average 7% PD-1+ leukocytes), (C) case 11 biopsy 1 (average 5% PD-L1+ leukocytes and 0% PD-L1+ HRS cells), and (D) case 11 biopsy 2 (average 10% PD-L1+ leukocytes and 100% PD-L1+ HRS cells). 
   <italic>Treated</italic>: (E) Case 29 primary biopsy (average 1% PD-1+ leukocytes), (F) case 29 relapse biopsy (average 16% PD-1+ leukocytes), (G) case 28 primary biopsy (average 10% PD-L1+ leukocytes and 0% PD-L1+ HRS cells), and (H) case 28 relapse biopsy (average 19% PD-L1+ leukocytes and 100% PD-L1+ HRS cells).
  </p>
 </caption>
 <graphic xlink:href="pone.0204870.g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
